OGI

Organigram Global Inc. (OGI) | Rumor.io

Organigram Global

OGI

Attention (50-day avg)0%

Attention rank (50-day avg)#1,149

Bullish sentiment (50-day avg)72%

Price to earnings ratio2.61

Market capitalization153M

Earnings per share0.42

Dividend yield (TTM)—

Revenue (annual)259.2M

Net income (annual)-24.8M

Social

What share of all stock conversation is about OGI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Aug 11

Organigram Global Inc. (OGI) reported a record third quarter with gross revenue of $145.1 million, a 32% year-over-year increase, and net revenue of $105.8 million, a 49% year-over-year increase.
The company's Sanity Group acquisition contributed approximately €25 million (C$40 million) in net revenue to Organigram's consolidated results since the acquisition closed on April 15, 2026.
Organigram maintained its position as the #1 market share in Canada, with #1 market share in vapes, milled flower, concentrates, and #2 in flower and pre-rolls, #3 in edibles, and #4 in beverages.

Generated by AI

Sentiment

Of the messages about OGI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	83.33% +11.81	71.63% -17.78
Bearish	—	—	16.67% -11.81	28.37% +17.78

Bullish· Aug 11

Organigram's Q3 revenue exceeded targets, reaching $105.9 million, a 49% increase, indicating a strong quarter for the company.
The new CEO is showing promising results, with the company's future looking very promising, and the CEO is considered a "BEAST" in the industry.
Organigram's adjusted EBITDA saw a significant 136% increase, and the company is expected to see a decrease in costs and an increase in profit in the coming years.

Bearish· Apr 4

The cannabis sector, in which OGI operates, is expected to be volatile until election time.
There are currently no buyers for OGI, indicating a lack of demand.
The recent volatility in the market is expected to persist.

Generated by AI

Topics

Of the messages about OGI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	10%	79.31%	40.25%
Technical Analysis	100%	90%	20.69%	8.37%
Earnings	0%	0%	0%	28.22%
Macro	0%	0%	0%	12.68%
Controversies	0%	0%	0%	0.97%
Analysts	0%	0%	0%	9.51%

Earnings· Aug 11

OGI delivered a record quarter with gross revenue of $145.1 million, a 32% year-over-year increase, and net revenue of $105.8 million, a 49% year-over-year increase.
OGI's adjusted EBITDA increased by 136% year-over-year to $13.4 million, and the company maintained its #1 market share in Canada across various segments.
OGI raised its FY26 revenue guidance above estimates, with a $145.1 million record quarter, and reported significant profitability, with some Canadian LPs finally seeing profitability.

Analysts· Sep 22

Organigram Global Inc. (OGI) has a potential price target of $30 by the end of 2023.
Analysts believe that full recreational legalization of cannabis in the US could be a catalyst for the company's growth.
Joe Biden's potential run on full recreational legalization in 2024 could positively impact OGI's stock performance.

Announcements· Dec 16

Organigram Global Inc. reported record fourth quarter and Fiscal 2025 results, including record annual revenue, adjusted EBITDA, and international sales.
The company achieved 62% revenue growth in fiscal 2025, driven by international sales and strategic acquisitions, with a strong outlook for fiscal 2026.
Organigram's Q4 2025 earnings showed record revenue and adjusted EBITDA, with net revenue surging 79% YoY to $80.1M, driven by the Motif acquisition and a 173% explosion in international sales for the year.

Technical Analysis· Nov 6

$OGI has a history of finishing green after a gap up, with 8 instances in the past.
The stock's recent addition to Parabolic Scan Tier III suggests it may be a volatile play with potential for continuation.
A break above VWAP at $1.53 could provide support for $OGI, which has been resistance for too long.

Generated by AI

Community

Of the messages about OGI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	84.38%	90.99%	62.47%
Newcomers	0%	15.63%	9.01%	37.53%

Regulars· Aug 11

Organigram Global Inc. (OGI) reports record third quarter fiscal 2026 results with gross revenue of $145.1 million, a 32% year-over-year increase, and net revenue of $105.8 million, a 49% year-over-year increase.
OGI maintains its #1 market share in Canada, with a strong presence in vapes, milled flower, concentrates, and other product categories, and its Sanity Group acquisition has contributed approximately €25 million (C$40 million) in net revenue to Organigram's consolidated results.
OGI's strong quarter and guidance raise have led to a significant price increase, with some participants noting that the company's performance has exceeded expectations and is a bullish sign for the future.

Newcomers· Aug 11

Newcomers are optimistic about Organigram Global Inc.'s profitability, citing improvements in Canadian LPs like Cronos and Cannara.
The stock's price is expected to increase, with some users predicting a 2.5x multiplier, but volume needs to pick up to support this growth.
Organigram Global Inc.'s earnings and future prospects are seen as promising, with some users noting impressive financial data and a strong trend.

Generated by AI

News

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

TORONTO, August 20, 2026--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI) ("Organigram" or the "Company") today announced an important milestone in its global growth strategy through the accelerated integration of Sanity Group GmbH ("Sanity") and the alignment of leadership, operations and market development activities across the combined organization.

1mo agoYahoo Finance

Organigram (OGI) Q3 2026 Earnings Call Transcript

Motley Fool Press Release.

1mo agoThe Globe and Mail

Also Discussed

Investors talking about OGI also mention

#	Name	Attention
1	Aurora Cannabis Inc.ACB	0%-0.01
2	Village Farms International Inc.VFF	0.01%-0.01
3	HEXO - HEXO Corp.	——
4	Tilray Brands Inc.TLRY	0.02%0
5	Canopy Growth CorporationCGC	0%-0.01
6	Cronos Group Inc.CRON	0%+0
7	High Tide Inc.HITI	0%-0.02
8	TrustCo Bank Corp. NYTRST	0%new
9	SNDL Inc.SNDL	0.01%+0
10	InterCure Ltd.INCR	0%new

Organigram Global Inc.

Healthcare
Drug Manufacturers - Specialty & Generic

Organigram Global Inc. is a cannabis company focused on the production and sale of cannabis and cannabis-derived products in Canada. The company serves both medical and adult-use recreational markets with a broad portfolio that includes whole flower, pre-rolls, vapes, beverages, gummies, concentrates, and other cannabis formats. Its product lineup is sold under well-known brands such as SHRED, Edison Cannabis Co., Big Bag O’ Buds, Monjour, Trailblazer, Boxhot, and DEBUNK. Organigram Global also participates in cannabinoid beverages and maintains a manufacturing and cultivation footprint across Canada to support indoor-grown cannabis production and product processing. Headquartered in Toronto, Ontario, the company is a licensed cultivator and manufacturer that plays a significant role in Canada’s regulated cannabis industry.

Website

Location

145 King Street West

Toronto, ON, M5H 1J8

Canada

Social

What share of all stock conversation is about OGI?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% +0	0% 0	0% 0

Aug 11

Organigram Global Inc. (OGI) reported a record third quarter with gross revenue of $145.1 million, a 32% year-over-year increase, and net revenue of $105.8 million, a 49% year-over-year increase.
The company's Sanity Group acquisition contributed approximately €25 million (C$40 million) in net revenue to Organigram's consolidated results since the acquisition closed on April 15, 2026.
Organigram maintained its position as the #1 market share in Canada, with #1 market share in vapes, milled flower, concentrates, and #2 in flower and pre-rolls, #3 in edibles, and #4 in beverages.

Generated by AI

Sentiment

Of the messages about OGI that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	83.33% +11.81	71.63% -17.78
Bearish	—	—	16.67% -11.81	28.37% +17.78

Bullish· Aug 11

Organigram's Q3 revenue exceeded targets, reaching $105.9 million, a 49% increase, indicating a strong quarter for the company.
The new CEO is showing promising results, with the company's future looking very promising, and the CEO is considered a "BEAST" in the industry.
Organigram's adjusted EBITDA saw a significant 136% increase, and the company is expected to see a decrease in costs and an increase in profit in the coming years.

Bearish· Apr 4

The cannabis sector, in which OGI operates, is expected to be volatile until election time.
There are currently no buyers for OGI, indicating a lack of demand.
The recent volatility in the market is expected to persist.

Generated by AI

Topics

Of the messages about OGI that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	0%	10%	79.31%	40.25%
Technical Analysis	100%	90%	20.69%	8.37%
Earnings	0%	0%	0%	28.22%
Macro	0%	0%	0%	12.68%
Controversies	0%	0%	0%	0.97%
Analysts	0%	0%	0%	9.51%

Earnings· Aug 11

OGI delivered a record quarter with gross revenue of $145.1 million, a 32% year-over-year increase, and net revenue of $105.8 million, a 49% year-over-year increase.
OGI's adjusted EBITDA increased by 136% year-over-year to $13.4 million, and the company maintained its #1 market share in Canada across various segments.
OGI raised its FY26 revenue guidance above estimates, with a $145.1 million record quarter, and reported significant profitability, with some Canadian LPs finally seeing profitability.

Analysts· Sep 22

Organigram Global Inc. (OGI) has a potential price target of $30 by the end of 2023.
Analysts believe that full recreational legalization of cannabis in the US could be a catalyst for the company's growth.
Joe Biden's potential run on full recreational legalization in 2024 could positively impact OGI's stock performance.

Announcements· Dec 16

Organigram Global Inc. reported record fourth quarter and Fiscal 2025 results, including record annual revenue, adjusted EBITDA, and international sales.
The company achieved 62% revenue growth in fiscal 2025, driven by international sales and strategic acquisitions, with a strong outlook for fiscal 2026.
Organigram's Q4 2025 earnings showed record revenue and adjusted EBITDA, with net revenue surging 79% YoY to $80.1M, driven by the Motif acquisition and a 173% explosion in international sales for the year.

Technical Analysis· Nov 6

$OGI has a history of finishing green after a gap up, with 8 instances in the past.
The stock's recent addition to Parabolic Scan Tier III suggests it may be a volatile play with potential for continuation.
A break above VWAP at $1.53 could provide support for $OGI, which has been resistance for too long.

Generated by AI

Community

Of the messages about OGI, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	84.38%	90.99%	62.47%
Newcomers	0%	15.63%	9.01%	37.53%

Regulars· Aug 11

Organigram Global Inc. (OGI) reports record third quarter fiscal 2026 results with gross revenue of $145.1 million, a 32% year-over-year increase, and net revenue of $105.8 million, a 49% year-over-year increase.
OGI maintains its #1 market share in Canada, with a strong presence in vapes, milled flower, concentrates, and other product categories, and its Sanity Group acquisition has contributed approximately €25 million (C$40 million) in net revenue to Organigram's consolidated results.
OGI's strong quarter and guidance raise have led to a significant price increase, with some participants noting that the company's performance has exceeded expectations and is a bullish sign for the future.

Newcomers· Aug 11

Newcomers are optimistic about Organigram Global Inc.'s profitability, citing improvements in Canadian LPs like Cronos and Cannara.
The stock's price is expected to increase, with some users predicting a 2.5x multiplier, but volume needs to pick up to support this growth.
Organigram Global Inc.'s earnings and future prospects are seen as promising, with some users noting impressive financial data and a strong trend.

Generated by AI

Organigram Global

Social

Aug 11

Bullish· Aug 11

Bearish· Apr 4

Earnings· Aug 11

Analysts· Sep 22

Announcements· Dec 16

Technical Analysis· Nov 6

Regulars· Aug 11

Newcomers· Aug 11

Organigram Remains Undervalued After Record-Breaking Quarter (NASDAQ:OGI)

Organigram Global to Host 2026 OG Investor Session

Organigram Global to Host 2026 OG Investor Session – Company Announcement

Organigram integrates Sanity Group, appoints new executives

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

Organigram (OGI) Q3 2026 Earnings Call Transcript

Also Discussed

Organigram Global Inc.

Company Information

Location

Organigram Remains Undervalued After Record-Breaking Quarter (NASDAQ:OGI)

Organigram Global to Host 2026 OG Investor Session

Organigram Global to Host 2026 OG Investor Session – Company Announcement

Organigram integrates Sanity Group, appoints new executives

Organigram Global Accelerates Integration of Sanity Group Under Unified Global Operating Structure

Organigram (OGI) Q3 2026 Earnings Call Transcript

Also Discussed

Social

Aug 11

Bullish· Aug 11

Bearish· Apr 4

Earnings· Aug 11

Analysts· Sep 22

Announcements· Dec 16

Technical Analysis· Nov 6

Regulars· Aug 11

Newcomers· Aug 11